Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pavol Harvanik
Observed name:
P. Harvanik
Institution:
University of Pavol Jozef Šafárik
Observed institution:
University of Pavol Jozef Šafárik
ORCID:
0009-0003-9900-9995
Observed ORCID:
0009-0003-9900-9995
OpenAlex ID:
A5114267336
Novel factors of cisplatin resistance in epithelial ovarian tumours
2025
·
Pavol Harvanik
, Martina Šemeláková
, et al.
·
Advances in Medical Sciences
·
8
Epitranscriptomic regulation in the progression of cancer and platinum resistance
2026
·
Pavol Harvanik
, Terézia Hudáková
, et al.
·
Advances in Medical Sciences
·
1
Current Prevalence of Hemoglobinopathies in the Slovak Population (2020–2024)
2025
·
Zuzana Solárová
, Angelika Vasiľová
, et al.
·
Bratislavské lekárske listy/Bratislava medical journal
·
1
Erythropoietin beyond red blood cells: Systemic and oncological functions (Review)
2026
·
Kristína Danková
, Zuzana Solárová
, et al.
·
Molecular Medicine Reports
PDF
Overexpression of scavenger receptor class B member 2 leads to different response of ovarian adenocarcinoma cells to chemotherapy
2026
·
Pavol Harvanik
, Zuzana Solárová
, et al.
·
Experimental Cell Research
Assessment the Effects of Roasted and Non‐Roasted Coffee Extracts on Colon Cancer Cells
2026
·
M. Šemeláková
, P. Bober
, et al.
·
Molecular Nutrition & Food Research
Overexpression of the erythropoietin receptor is associated with upregulation of tubulin beta 6 and paclitaxel resistance in ovarian adenocarcinoma cells
2026
·
Pavol Harvanik
, Kristína Danková
, et al.
·
Acta chimica slovenica
PDF
Overexpression of biliverdin reductase A leads to ROS-independent sensitization of ovarian adenocarcinoma cells to gemcitabine
2026
·
Zuzana Solárová
, Kristína Danková
, et al.
·
Experimental Cell Research
Show more works
View as search
Works count:
8
Citation count:
10
H-index:
1
I10-index:
Year
Topic
Type